Relations of inflammatory markers to lipid levels and autonomic tone in patients with moderate and severe chronic kidney disease and in patients under maintenance hemodialysis

Clinical Nephrology

Volumn 64, Issue 6, 2005, Pages 419-427

  Psychari, Stavroula N ^a   Sinos, L ^a   Iatrou, C ^a   Liakos, G ^a   Apostolou, T S ^a  

^a Nikea General Hospital Athens   (Greece)

Author keywords

Autonomic tone; C reactive protein; Heart rate variability; Interleukin 6; Lipid levels; Renal failure

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEART RATE VARIABILITY; HEMODIALYSIS; HUMAN; INFLAMMATION; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; RR INTERVAL; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS;

EID: 29244469073     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp64419     Document Type: Article

References (38)

1. Aronson D, Mittleman MA, Burger AJ 2001 Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. J Cardiovasc Electrophysiol 12: 294-300
2. Basile C, Casino F, Lopez T 1990 Percent reduction in blood urea concentration during dialysis estimates Kt/V in a simple and accurate way. Am J Kidney Dis 15: 40-45
3. Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur A Stenzel KH, Rubin AL 1998 Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia and mortality in hemodialysis patients. Am J Kidney Dis 32: 107-114
4. Campese V, Rommof M, Levitan D, Lane K, Massry S 1981 Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int 20: 246-253
5. Cockcroft DW, Gault MH 1976 Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41
6. DeRijk RH, Boelen A, Tilders FJ, Berkenbosch F 1994 Induction of plasma interleukin-6 by circulating adrenaline in rat. Psychoneuroendocrinology 19: 155-163
7. Elenkov IJ, Wilder RL, Chrousos GP, Vizi SE 2000 The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52: 595-638
8. Giordano M. Manzella D, Paolisso G, Caliendo A, Varricchio M, Giordano C 2001 Differences in heart rate variability parameters during the post-dialytic period in type II diabetic and non-diabetic ESRD patients. Nephrol Dial Transplant 16: 566-573
9. Irish A 1998 Cardiovascular disease, fibrinogen and the acute-phase response. Associations with lipids and blood pressure in patients with chronic renal disease. Atherosclerosis 137: 133-139
10. Iseki K, Yamazato M, Tozawa M Takishita S 2002 Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int 61: 1887-1893
11. Jialal I, Stein D, Balis D, Grundy SM, Adams-Huet B, Devaraj S 2001 Effect of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy on high sensitivity C-reactive protein levels. Circulation 103: 1933-1935
12. Kalantar-Zadeh K, Block G, Humphreys MH, Copple JD 2003 Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63: 793-808
13. Kaysen GA 2001 The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 12: 1549-1557
14. Kurata C, Uehara A, Sugi T, Ishigawa A, Fujita K, Yonemura K, Hishida A, Ishikawa K, Tawarahara K, Shouda S, Mikami T 2000 Cardiac autonomic neuropathy in patients with chronic renal failure on hemodialysis. Nephron 84: 312-319
15. Laaksonen S, Voipio-Pulkki L-M, Erkinjuntti M, Asola M, Falck B 2000 Does dialysis therapy improve autonomic and peripheral nervous system abnormalities in chronic uremia? J Int Med 248: 21-26
16. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G 2003 National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification and stratification. Ann Intern Med 139: 137-147
17. Lombardi F 2004 Sympathetic activation and sub-clinical inflammation: a new combination to identify high risk subjects. Eur Heart J 25: 359-360
18. Madden KS, Felten SY, Felten DL 1994 Sympathetic nervous system modulation of the immune system. Induction of lymphocyte proliferation and migration in vivo by chemical sympathectomy. J Neuroimmunol 49: 67-75
19. Malik S, Winney RJ, Ewing DJ 1986 Chronic renal failure and cardiovascular autonomic function. Nephron 43: 191-195
20. Malpas SC, Maling TJB 1990 Heart Tate variability and cardiac autonomic function in diabetes. Diabetes 39: 177-1181
21. März P, Cheng JG, Gadient PA, Patterson PH, Stoyan T, Otten U, Rose-John S 1998 Sympathetic neurons can produce and respond to interleukin 6. Proc Natl Acad Sci USA 95: 3251-3256
22. Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowley A, Prescott RJ, Neilson JM, Fox KA 1998 Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assesment of risk trial (UK-heart). Circulation 98: 1510-1516
23. Papanicolaou DA, Petrides JS, Tsigos C, Bina S, Kalogeras KT, Wilder R, Gold PW 1996 Exersise stimulates interleukin-6 secretion. Inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol 271: E601-E605
24. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP 1998 The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128: 127-137
25. Pereira BJ, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA 1994 Plasma levels of IL-1-beta, TNF-alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 45: 890-896
26. Rauchhaus M, Coats AJS, Anker SD 2000 The endotoxin-lipoprotein hypothesis. Lancet 356: 930-933
27. Sadrone G, Mortara A, Torzillo D, La Rovere MT, Malliani A, Lombardi F 1994 Effects of beta-blockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction. Am J Cardiol 74: 340-345
28. Sajadieh A, Wendelboe Nielsen O, Rassmussen V, Hein HO, Abedini S, Jorgen FH 2004 Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 25: 363-370
29. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furgerg CD, Psaty BM 2003 Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107: 87-92
30. Steinberg AA, Mars RL, Goldman DS, Percy RF 1998 Effect of end-stage renal disease on decreased heart rate variability. Am J Cardiol 82: 1156-1158
31. Stenvinkel P, Heimbürger O, Tuck CH, Berglund L 1998 Apo(a) isoform size, nutritional status and inflammatory markers in chronic renal failure. Kidney Int 53: 1336-1342
32. Tamura K, Tsuji H, Nishiue T, Yajima I, Higashi T, Iwasaka T 1998 Determinants of heart rate variability in chronic hemodialysis patients. Am J Kidney Dis 31: 602-606
33. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology 1996 Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93: 1043-1065
34. Third Report of the National Cholesterol Education Program (NCEP) 2002 Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III): final report. Circulation 106: 3143-3421
35. Toussirot E, Bahjaoui-Bouhhadi M, Poncet JC, Cappelle S, Henriet MT, Wendling D, Regnard J 1999 Abnormal autonomic cardiovascular control in ankylosing spondylitis. Ann Rheum Dis 58: 481-487
36. Tsuji H, Venditti FJ, Manders ES, Evans JC, Larson MG, Feldman CL, Levy D 1996 Determinants of heart rate variability. J Am Coll Cardiol 28: 1539-1546
37. Vita G, Savica V, Puglisi RM, Marabello L, Bellinghieri G, Messina C 1992 The course of autonomic neural function in chronic uremic patients during hemodialysis treatment. Nephrol Dial Transplant 7: 1022
38. Wejss G 1999 Iron and anemia of chronic disease. Kidney Int Suppl 69: S12-S17